• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国北方一家三级医院中异质性万古霉素中介金黄色葡萄球菌的流行及分子特征。

Prevalence and molecular characteristics of heterogeneous vancomycin intermediate Staphylococcus aureus in a tertiary care center of northern China.

机构信息

Clinical Laboratory Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.

Department of Gynecology and Obstetrics, Hua Zhong University of Science and Technology Union Shenzhen Hospital, Shenzhen 518000, China.

出版信息

Diagn Microbiol Infect Dis. 2024 Mar;108(3):116180. doi: 10.1016/j.diagmicrobio.2024.116180. Epub 2024 Jan 4.

DOI:10.1016/j.diagmicrobio.2024.116180
PMID:38183897
Abstract

The use of glycopeptide medications may decline in line with the annual decline in methicillin-resistant Staphylococcus aureus (MRSA) detection rates in China. The rate of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)detection may be impacted by this. However, there is currently a dearth of information on the incidence of hVISA in China. This study aims to analyze the recent epidemiology and molecular characteristics of hVISA strains in Beijing, China. A total of 175 non-duplicate MRSA strains from various infection sites were collected from a medical center between January 2018 and May 2023 and underwent molecular typing and susceptibility testing (Vitek2). Vancomycin and teicoplanin MICs were also evaluated by standard broth microdilution method and agar dilution method, respectively. Isolates growing on screening agar (BHIV4 and BHIT5, brain heart infusion agar containing 4 μg/ml vancomycin and 5 μg/ml teicoplanin, respectively) were characterized further by analysis of macro-Etest (MET) and population analysis profiling with area under the curve (PAP-AUC). The proportion of hVISA among MRSA isolates was 8.6 %. BHIT5 could select all hVISA strains while BHIV4 and MET only selected two hVISA strains. Compared with vancomycin- susceptible Staphylococcus aureus (VSSA), hVISA isolates were less susceptible to erythromycin and clindamycin. In addition, hVISA frequency was MIC-independent despite using different detection methods. In total, 11 types of STs, 28 types of spa typing, four types of SCCmec typing, and two types of agr typing were identified and the predominant type in both MRSA and hVISA isolates was ST239-t030-SCCmecIII-agr I. The analysis of biofilm formation, growth, and virulence genes in hVISA strains revealed sparse information. The dataset presented in this study provided the prevalence and molecular characteristics of hVISA in hospital settings and the combination of BHIT5 and PAP-AUC may identify hVISA efficiently. The result of genotyping suggested the genotype of hVISA was mainly consistent with that of local MRSA. Additional studies on the characteristics of hVISA strains were necessary.

摘要

糖肽类药物的使用可能会随着中国耐甲氧西林金黄色葡萄球菌 (MRSA) 检出率的逐年下降而减少。这可能会影响异质性万古霉素中介金黄色葡萄球菌 (hVISA) 的检出率。然而,目前中国关于 hVISA 发病率的信息还很匮乏。本研究旨在分析中国北京地区 hVISA 菌株的近期流行病学和分子特征。从 2018 年 1 月至 2023 年 5 月,从一家医疗中心采集了来自不同感染部位的 175 株非重复 MRSA 菌株,进行了分子分型和药敏试验(Vitek2)。还通过标准肉汤微量稀释法和琼脂稀释法分别评估了万古霉素和替考拉宁的 MIC 值。在筛选琼脂(BHIV4 和 BHIT5,分别含有 4μg/ml 万古霉素和 5μg/ml 替考拉宁的脑心浸液琼脂)上生长的分离物通过宏检测(MET)和面积下曲线的种群分析轮廓(PAP-AUC)分析进一步表征。MRSA 分离株中 hVISA 的比例为 8.6%。BHIT5 可以选择所有 hVISA 菌株,而 BHIV4 和 MET 仅选择两株 hVISA 菌株。与万古霉素敏感金黄色葡萄球菌 (VSSA) 相比,hVISA 分离株对红霉素和克林霉素的敏感性较低。此外,尽管使用不同的检测方法,但 hVISA 频率与 MIC 无关。总共鉴定出 11 种 ST 型、28 种 spa 型、4 种 SCCmec 型和 2 种 agr 型,MRSA 和 hVISA 分离株的主要类型均为 ST239-t030-SCCmecIII-agr I。hVISA 菌株生物膜形成、生长和毒力基因分析的结果信息稀疏。本研究提供了医院环境中 hVISA 的流行率和分子特征,BHIT5 和 PAP-AUC 的结合可能有效地识别 hVISA。基因分型结果表明,hVISA 的基因型主要与当地的 MRSA 一致。需要进一步研究 hVISA 菌株的特征。

相似文献

1
Prevalence and molecular characteristics of heterogeneous vancomycin intermediate Staphylococcus aureus in a tertiary care center of northern China.中国北方一家三级医院中异质性万古霉素中介金黄色葡萄球菌的流行及分子特征。
Diagn Microbiol Infect Dis. 2024 Mar;108(3):116180. doi: 10.1016/j.diagmicrobio.2024.116180. Epub 2024 Jan 4.
2
Molecular and Clinical Features of Heterogeneous Vancomycin-Intermediate in Tertiary Care Hospitals in South India.印度南部三级保健医院中异质性万古霉素中介的分子和临床特征。
Sultan Qaboos Univ Med J. 2023 Nov;23(4):447-454. doi: 10.18295/squmj.3.2023.018. Epub 2023 Nov 30.
3
Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013.台湾地区高万古霉素最小抑菌浓度的耐甲氧西林金黄色葡萄球菌中万古霉素中介金黄色葡萄球菌(VISA)和异质性 VISA 的流行情况:一项 2012-2013 年多中心监测研究。
J Microbiol Immunol Infect. 2016 Oct;49(5):701-707. doi: 10.1016/j.jmii.2015.07.003. Epub 2015 Jul 31.
4
[The incidence and risk factors for heterogeneous vancomycin intermediate Staphylococcus aureus].[异质性万古霉素中介金黄色葡萄球菌的发病率及危险因素]
Zhonghua Nei Ke Za Zhi. 2013 Apr;52(4):318-22.
5
High prevalence of a globally disseminated hypervirulent clone, Staphylococcus aureus CC121, with reduced vancomycin susceptibility in community settings in China.高流行率的一种在全球传播的高毒力克隆株,金黄色葡萄球菌 CC121,在中国社区环境中对万古霉素的敏感性降低。
J Antimicrob Chemother. 2019 Sep 1;74(9):2537-2543. doi: 10.1093/jac/dkz232.
6
Detection of heterogeneous vancomycin-intermediate : A preliminary report from south India.印度南部地区异质性万古霉素中介的检测:初步报告。
Indian J Med Res. 2019 Aug;150(2):194-198. doi: 10.4103/ijmr.IJMR_1976_17.
7
Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States.美国耐万古霉素异质性中间水平金黄色葡萄球菌分离株的检测。
J Clin Microbiol. 2011 Dec;49(12):4203-7. doi: 10.1128/JCM.01152-11. Epub 2011 Oct 5.
8
Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey.万古霉素和达托霉素最低抑菌浓度分布及土耳其耐甲氧西林金黄色葡萄球菌血分离株异质性耐药的发生。
BMC Infect Dis. 2013 Dec 10;13:583. doi: 10.1186/1471-2334-13-583.
9
Reduced vancomycin susceptibility found in methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical isolates in Northeast China.在中国东北地区发现耐甲氧西林和甲氧西林敏感金黄色葡萄球菌临床分离株中万古霉素敏感性降低。
PLoS One. 2013 Sep 12;8(9):e73300. doi: 10.1371/journal.pone.0073300. eCollection 2013.
10
The Prevalence of Vancomycin-Intermediate Staphylococcus aureus and Heterogeneous VISA Among Methicillin-Resistant Strains Isolated from Pediatric Population in a Turkish University Hospital.土耳其某大学医院分离出的耐甲氧西林菌株中万古霉素中介金黄色葡萄球菌和异质性万古霉素中介金黄色葡萄球菌的患病率
Microb Drug Resist. 2015 Oct;21(5):537-44. doi: 10.1089/mdr.2015.0048. Epub 2015 Apr 28.

引用本文的文献

1
Newly isolated terpenoids (covering 2019-2024) from Aspergillus species and their potential for the discovery of novel antimicrobials.从曲霉属物种中最新分离出的萜类化合物(涵盖2019年至2024年)及其发现新型抗菌剂的潜力。
Nat Prod Bioprospect. 2025 Mar 18;15(1):19. doi: 10.1007/s13659-025-00501-2.
2
Adaptive physiological and metabolic alterations in Staphylococcus aureus evolution under vancomycin exposure.万古霉素暴露下金黄色葡萄球菌进化中的适应性生理和代谢改变。
World J Microbiol Biotechnol. 2024 Sep 16;40(10):322. doi: 10.1007/s11274-024-04128-2.
3
Recent development and fighting strategies for lincosamide antibiotic resistance.
林可酰胺类抗生素耐药性的最新研究进展与应对策略。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0016123. doi: 10.1128/cmr.00161-23. Epub 2024 Apr 18.